Navigation Links
"AWAKEN" Survey Finds Only 50 Percent of Americans Understand Significant Health Impact of Narcolepsy, and Many Physicians Not Comfortable Diagnosing the Sleep Disorder
Date:6/11/2012

ith narcolepsy, we're dedicated to improving awareness of this serious disorder and helping the sleep community tackle misunderstanding, misperceptions and misdiagnosis," said Bruce Cozadd, chairman and chief executive officer of Jazz Pharmaceuticals.

The company also supports a variety of patient and medical education initiatives to help improve awareness of narcolepsy, its diagnosis and treatment.  As part of SLEEP 2012, the 26th Annual Meeting of the Associated Professional Sleep Societies (APSS) in Boston, Jazz Pharmaceuticals provided an educational grant for a continuing medical education roundtable titled "Optimizing Care for the Narcolepsy Patient," where experts discussed the clinical features and diagnosis of narcolepsy and challenges in patient care.

About AWAKEN
The AWAKEN Survey: Awareness and Knowledge of Narcolepsy is a national online survey commissioned by Jazz Pharmaceuticals and conducted by Harris Interactive in May 2012. The survey was conducted among 1,000 adults (general public, 18+), 300 primary care physicians (general practice, family practice and internal medicine) and 100 sleep specialists (neurologists, psychiatrists, pulmonologists and PCPs) to discern the level of public and physician knowledge of narcolepsy.  All physician respondents have practiced 2-30 years, spend at least 75% of their professional time in direct patient care and treat at least 50 patients per month for any condition. Sleep specialist respondents are neurologists, psychiatrists or pulmonologists who treat at least 30 patients a month for sleep disorders, or are primary care physicians who treat at least 30 patients a month for sleep disorders and are board-certified in sleep medicine.

About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc is a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing and commercializing products that address unmet medical needs.  The co
'/>"/>

SOURCE Jazz Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Global Medical Devices Survey 2012-2013: Market Trends, Buyer Spend and Procurement Strategies in the Global Medical Devices Industry
2. Global Pharmaceutical Survey 2012-2013: Market Trends, Buyer Spend and Procurement Strategies in the Global Pharmaceutical Industry
3. Global Pharmaceutical Survey 2012-2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry
4. Survey Shows eContent Critical to Corporate Strategies
5. As Smartphone Usage Expands, Survey Says Nurses and Nursing Students Want Mobile Access to Credible Drug Data
6. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
7. CVS Caremark Sponsored Research Finds FDA Drug Warnings Can Have Immediate Negative Impact on Medication Adherence, Even if Not Related to Safety
8. First, do no harm: Study finds danger in standard treatment for a serious lung disease
9. Life Extension Foundation® study finds Cognitex® with NeuroProtection Complex may provide a positive impact on cognitive performance
10. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
11. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... Omeros Corporation (NASDAQ: OMER ), ... commercializing both small-molecule and protein therapeutics for large-market ... and disorders of the central nervous system, today ... quarter 2015 financial results for the period ended ... after market close. Omeros management will host a ...
(Date:5/5/2015)... 2015  InMed Pharmaceuticals Inc. ("InMed") (CSE: IN; ... specializes in developing safer, more effective cannabis-based therapies, ... and Non-Executive Director, Peter Mountford , has ... primary responsibility for the European markets. ... his previous success in the emerging field of ...
(Date:5/4/2015)... and VANCOUVER, British Columbia ... OGXI ) announced today that it will report ... 14, 2015. Company management will host a conference call ... provide an overview of financial results, clinical development programs ... access the webcast, log on to the Investor Relations ...
Breaking Medicine Technology:Omeros Corporation to Announce First Quarter 2015 Financial Results on May 11, 2015 2InMed Engages Peter Mountford as Strategic Advisor 2InMed Engages Peter Mountford as Strategic Advisor 3InMed Engages Peter Mountford as Strategic Advisor 4
... CS, a cancer survivorship case management software program jointly ... ) and Equicare Health, Inc., has been included by ... in its "Best Practices Repository." The repository is a ... in the U.S. adopt rigorous standards for high-quality patient-centered ...
... May 29, 2012  Echo Therapeutics, Inc. (Nasdaq: ... Symphony® tCGM System as a non-invasive, wireless, transdermal ... System for transdermal drug delivery, today announced that ... Echo Therapeutics will present at the Jefferies 2012 ...
Cached Medicine Technology:EQUICARE CS Cancer Survivorship Case Management Software Listed as a "Best Practices" Resource by the American College of Surgeons Commission on Cancer (COC) 2EQUICARE CS Cancer Survivorship Case Management Software Listed as a "Best Practices" Resource by the American College of Surgeons Commission on Cancer (COC) 3Echo Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference 2Echo Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference 3
(Date:5/5/2015)... May 05, 2015 Buckeye Health Plan ... new CEO and plan president of Buckeye Health Plan. ... the position immediately. , Hill has more than 28 ... the Pacific Northwest, from managed care to large health ... and CEO of HealthPlus of Michigan, a health plan ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 Igantia ... San Francisco, leads an international initiative to examine key ... extend the human lifespan. Scientists at Igantia believe ... women, from the initiation of her menstrual cycle to ... mechanism for aging and, ultimately, extend the lifespan. ...
(Date:5/5/2015)... 2015 HealthSlide, Inc ., ... solutions for hospitals nationwide, has announced the launch ... CIOs and CTOs can access the calculator on ... both initial and ongoing savings of switching to ... nation’s hospitals pay an average of $300,000 a ...
(Date:5/5/2015)... 05, 2015 After record-breaking sales of ... 2014, Walgreens introduces the Cookies & Cream flavor at ... Extend Nutrition has continually raised the bar for nutritional ... combined with an unprecedented nutritional profile, backed by international ... Extend Nutrition will launch additional new products and expand ...
(Date:5/5/2015)... May 05, 2015 Every year, news articles ... Turns out, the worst dry eye season is spring, also ... in most of the United States. The only season offering ... advocate Sharon Kleyne, host of the Sharon Kleyne Hour™ Power ... her radio show of May 11, 2015. Kleyne is the ...
Breaking Medicine News(10 mins):Health News:Buckeye Health Plan Announces New Chief Executive Officer 2Health News:Buckeye Health Plan Announces New Chief Executive Officer 3Health News:Igantia Announces Digital Initiative to Decode Longevity 2Health News:HealthSlide Launches ROI Cost Calculator 2Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 2Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 3Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 4Health News:Nature’s Tears EyeMist tear film supplement soothes dry eye caused by spring pollen season, reports inventor Sharon Kleyne 2Health News:Nature’s Tears EyeMist tear film supplement soothes dry eye caused by spring pollen season, reports inventor Sharon Kleyne 3
... According to findings of a recent study researchers say bypass ... for many patients // with blocked heart arteries . ... on-pump (work of the heart is shifted to a mechanical ... still beating) surgery. Results of the surgeries were evaluated one ...
... in addition to medication show an improved clinical recovery ... to a new study. ,Researchers examined 126 patients ... in the middle cerebral artery. All the patients were ... of symptom onset. 63 patients were randomly assigned to ...
... cardiovascular disease risk factors, which include high blood pressure, impaired ... the condition is made if you have three out of ... risk for cardiovascular disease. According to a new study, starting ... add extra risk. ,Based on findings of the study ...
... and one of the most frequent causes of indigestion. Typical ... cases. Smoking and a high salt intake significantly increase the ... study. ,Results of the study showed that people ... 70-percent more likely to have acid reflux than non-smokers. Those ...
... more over several years puts one at greater risk for heart ... weight . ,Researchers studied nearly 2,500 adults between ages ... or more during the study, and 20 percent of these people ... and diabetes. But only 4 percent of those who didn't gain ...
... new study shows that not being in optimum cardiovascular health ... say researchers .// ,Researchers say they have found ... cognitive impairment in the elderly. The conditions of metabolic syndrome ... blood glucose levels, high blood pressure, and low levels of ...
Cached Medicine News:
Legionella IgG/M ELISA....
Measles IgM ELISA....
... The Wampole EBV ELISA test ... of assays for the determination ... tests for Viral Capsid Antigen ... Nuclear Antigen (EBNA). Most Wampole ...
Toxo IgG ELISA. All Wampole ELISA kits include the following: 12 x 8 well strips with breakaway wells, sample diluent, controls and calibrators, conjugate, TMB substrate, wash buffer, stop solution,...
Medicine Products: